| Justin Almond, PHARMD | |
|
305 W Quinn Rd, Pocatello, ID 83201-4988 | |
| (208) 238-4049 | |
| Not Available |
| Full Name | Justin Almond |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 305 W Quinn Rd, Pocatello, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033752662 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | P8375 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Justin Almond, PHARMD 305 W Quinn Rd, Pocatello, ID 83201-4988 Ph: (208) 238-4049 | Justin Almond, PHARMD 305 W Quinn Rd, Pocatello, ID 83201-4988 Ph: (208) 238-4049 |
News Archive
An editorial published by The BMJ today raises important concerns about the health and wellbeing of the NHS workforce after a parliamentary report found "burnout is a widespread reality in today's NHS."
Genentech, Inc. and XOMA Ltd. today announced preliminary results of a randomized, placebo-controlled Phase II study with RAPTIVA™ (efalizumab) in 107 patients with psoriatic arthritis. The study did not reach statistical significance at 12 weeks (84 days) for the primary endpoint, ACR 20 response. An ACR 20 response indicates at least a 20 percent improvement in an individual's signs and symptoms of arthritis.
The Bill & Melinda Gates Foundation and China's Ministry of Science and Technology (MOST) on Wednesday signed a Memorandum of Understanding to form a partnership to support new research and development (R&D) and production of new products for global health and agriculture, Agence France-Presse reports.
AbbVie, a global biopharmaceutical company, today announced data from the SURVEYOR studies of its investigational HCV regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, that show high rates of sustained virologic response at 12 weeks post-treatment (SVR 12) in non-cirrhotic patients with chronic hepatitis C virus (HCV) infection.
The first symptom of Parkinson's disease is often an impaired sense of smell. This neurodegenerative disease primarily causes irreparable damage to nerve cells in a brain area involved in movement control.
› Verified 7 days ago
Dr. Roger Franklin Murphy, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1015 E Young St, Pocatello, ID 83201 Phone: 208-232-0049 Fax: 208-232-3963 | |
Dr. Jordin Millward, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 465 Memorial Dr, Pocatello, ID 83201 Phone: 208-282-3387 | |
Frances Mary Huber, DR Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 333 W Center St, Pocatello, ID 83204 Phone: 208-233-2063 | |
Spencer Adams, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Yellowstone Ave, Pocatello, ID 83201 Phone: 208-239-4033 Fax: 208-239-4027 | |
Dr. Donelle Airmet, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 990 S 8th Ave, Pocatello, ID 83209 Phone: 208-282-3407 | |
Mrs. Cristina Maria Da Silva Comparini, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1957 Alvin Ricken Dr, Pocatello, ID 83201 Phone: 208-236-6340 |